MedPath

CENTRE OSCAR LAMBRET

CENTRE OSCAR LAMBRET logo
🇫🇷France
Ownership
Private
Established
1995-01-01
Employees
251
Market Cap
-
Website
http://www.centreoscarlambret.fr

Clinical Trials

150

Active:33
Completed:60

Trial Phases

5 Phases

Phase 1:20
Phase 2:36
Phase 3:9
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (116 trials with phase data)• Click on a phase to view related trials

Not Applicable
48 (41.4%)
Phase 2
36 (31.0%)
Phase 1
20 (17.2%)
Phase 3
9 (7.8%)
Phase 4
2 (1.7%)
phase_1_2
1 (0.9%)

Prospective Clinico-biological Database of Patients With Ovarian and/or Peritoneal and/or Fallopian Tube Carcinoma

Not Applicable
Recruiting
Conditions
Cancer of the Ovary
Cancer of the Fallopian Tube
Peritoneal Cancer
First Posted Date
2025-05-14
Last Posted Date
2025-06-29
Lead Sponsor
Centre Oscar Lambret
Target Recruit Count
371
Registration Number
NCT06969833
Locations
🇫🇷

Centre Oscar Lambret, Lille, France

Factors Sustaining Tobacco Abstinence in Cancer Patients Treated With Radio-chemotherapy or Radiotherapy

Recruiting
Conditions
Smoking Cessation
Nicotine Addiction
Nicotine Dependence
Smoking
Head and Neck Neoplasms
First Posted Date
2025-04-04
Last Posted Date
2025-04-06
Lead Sponsor
Centre Oscar Lambret
Target Recruit Count
100
Registration Number
NCT06910566
Locations
🇫🇷

Centre Oscar Lambret, Lille, France

Efficacy and Safety of Vaginal Radiofrequency for Vulvovaginal Atrophy in Breast Cancer Patients

Not Applicable
Recruiting
Conditions
Vaginal Dryness
Breast Cancer
Vulvovaginal Atrophy
First Posted Date
2025-03-28
Last Posted Date
2025-07-03
Lead Sponsor
Centre Oscar Lambret
Target Recruit Count
75
Registration Number
NCT06900374
Locations
🇫🇷

Centre Oscar Lambret, Lille, France

Serratus Plane Block (SPB) Versus Capsaïcine Versus Botox-A for Chronic Neuropathic Pain in Post-mastectomy Syndrome

Phase 2
Recruiting
Conditions
Post-Mastectomy Neuropathic Pain Syndrome
Interventions
Procedure: Serratus Plane Block
Procedure: Botulinum Toxin A
First Posted Date
2025-02-04
Last Posted Date
2025-06-22
Lead Sponsor
Centre Oscar Lambret
Target Recruit Count
123
Registration Number
NCT06807164
Locations
🇫🇷

Centre Oscar Lambret, Lille, Hauts-de-France, France

Risk-reducing Strategies, Including Fimbriectomy, in Women With a Germline Mutation Predisposing to Ovarian or Pelvic Cancer

Not Applicable
Not yet recruiting
Conditions
Tubo-ovarian Carcinoma
High-grade Serous Carcinoma
Primary Peritoneal Carcinoma Stage III
Primary Peritoneal Carcinoma Stage IV
Primary Peritoneal Carcinoma
First Posted Date
2024-12-10
Last Posted Date
2024-12-10
Lead Sponsor
Centre Oscar Lambret
Target Recruit Count
1100
Registration Number
NCT06726330
Locations
🇫🇷

Institut Bergonié, Bordeaux, France

🇫🇷

Centre François Baclesse, Caen, France

🇫🇷

Centre Jean Perrin, Clermont-Ferrand, France

and more 20 locations
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 26
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath